MWMichael A. Weingarten

Michael A. Weingarten

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michael A. Weingarten has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The ethics of basing community prevention in general practice

    by Michael Weingarten, Andre Matalon

    In this paper we argue that the responsibility for systematic community-based preventive medicine should not be made part of the role of the general practitioner (GP). Preventive medicine cannot be shown to be more effective than curative or supportive medicine. Therefore, the allocation of the large amount of general practice staff time and resources required for systematic preventive medicine should not come at the expense of the care of the sick and the suffering. The traditional healing role of the GP requires a cooperative patient-centred approach, whereas systematic preventive medicine is driven by rigid pre-set protocols and is intrinsically paternalistic. Trying to merge the two approaches is detrimental to the doctor-patient relationship. Furthermore, a number of potential pitfalls are identified that may be encountered in the implementation of preventive medicine programmes in general practice: interference with the course of the consultation; inadequate explanation and consent; distortion of practice priorities as reflected in quality indicators; temptation to record inaccurate data; conflict of interests where the doctor is rewarded for performance; patient blaming; exacerbation of the health gap. We suggest that a more justifiable strategy would be for GPs to identify patients at high risk and offer them specific preventive advice when the opportunity presents itself and at a time when the patient is likely to be most amenable to cooperate. Opportunistic health promotion offers higher expectations of benefit, as well as a more equitable allocation of the risks associated with preventive medicine, than a systematic community-based approach.


  • Open Access

    An anatomy of conflicts in primary care encounters: a multi-method study

    by Michael A Weingarten, Nurit Guttman, Henry Abramovitch, Ruth Stashevsky Margalit, Debra Roter, Amitai Ziv, John Yaphe, Jeffrey M Borkan

    Background. Medical consultations are replete with conflicts, particularly in the current era of explicit and implicit rationing practices in health care organizations. Although such conflicts may challenge the doctor–patient relationship, little is known about them or their consequences. Aims. To systematically describe the nature of doctor–patient conflicts in medical encounters and the strategies physicians use when faced with conflicts. Methods. Analysis of 291 videotaped routine encounters with 28 general practitioners, using a novel adaptation of the Roter interaction analysis system software, provided quantitative empirical data on the conflicts and on the communication process. Seven focus groups (56 GPs) provided qualitative insights and guided the analysis. Results. Conflicts were identified in 40% of consultations; 21% of these were related to the rationing of health care resources. In conflictual encounters, both the opening and closing phases of the encounter were shorter than in non-conflictual encounters. In coping with resource rationing, the commonest strategy was to accept the dictates of the system without telling the patients about other options. When conflict of this type occurred, doctors showed more opposition to the patients rather than empathy. Conclusions. Doctors often face conflicts in their routine work, but resource-related conflicts are especially difficult and expose the dual loyalties of the doctor to the patient and to the system. Insights derived from this research can be used to design training interventions that improve doctors’ efficacy in coping with conflicts and ultimately allow them to provide better patient care.


  • Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps

    by Michael Asher Ma Weingarten, Anca Zalmanovici Trestioreanu, John Yaphe

    Several dietary factors have been considered to be involved in the increasing incidence of colorectal cancer in industrialised countries. Experimental and epidemiological evidence has been suggestive but not conclusive for a protective role for high dietary calcium intake. Intervention studies with colorectal cancer as an endpoint are difficult to perform owing to the large number of patients and the long follow‐up required; studies using the appearance of colorectal adenomatous polyps as a surrogate endpoint are therefore considered in reviewing the existing evidence. This systematic review aims to assess the effect of supplementary dietary calcium on the incidence of colorectal cancer and the incidence or recurrence of adenomatous polyps. We searched the Cochrane Controlled Trials Register, the Cochrane Colorectal Cancer Group specialised register, MEDLINE, Cancerlit , and Embase, to December 2009. The reference lists of identified studies were inspected for further studies, and the review literature was scrutinized. Randomised controlled trials of the effects of dietary calcium on the development of colonic cancer and adenomatous polyps in humans are reviewed. Studies of healthy adults and studies of adults at higher risk of colon cancer due to family history, previous adenomatous polyps, or inflammatory bowel disease were considered; data from subjects with familial polyposis coli are excluded. The primary outcomes were the occurrence of colon cancer, and occurrence or recurrence of any new adenomas of the colon. Secondary outcomes were any adverse event that required discontinuation of calcium supplementation, and drop‐outs before the end of the study. Two reviewers independently extracted data, assessed trial quality and resolved discrepancies by consensus. The outcomes were reported as odds ratios (OR) with 95% confidence intervals (CI). The data were combined with the fixed effects model. Two studies with 1346 subjects met the inclusion criteria. Both trials were well designed, double ‐ blind, placebo controlled trials, included participants with previous adenomas. The doses of supplementary elemental calcium used were 1200 mg daily for a mean duration of 4 years, and 2000 mg/day for three years.The rates of loss to follow ‐up were 14 % and 11%. For the development of recurrent colorectal adenoma, a reduction was found (OR 0.74, CI 0.58,0.95) when the results from both trials were combined. Although the evidence from two RCTs suggests that calcium supplementation might contribute to a moderate degree to the prevention of colorectal adenomatous polyps, this does not constitute sufficient evidence to recommend the general use of calcium supplements to prevent colorectal cancer. 利用日常補充鈣質來預防大腸癌和大腸息肉症的發生 在工業國家中,有許多飲食因子都被認為與大腸癌發生機率的提升有關,實驗性和流行病學推測(但不是結論)經由飲食攝取高量的鈣質可能有助預防大腸癌,利用大腸癌的發作為終止點所進行的介入性研究並不容易進行,因為病患人數太多,且需要進行長期的後續照護,因此利用出現大腸息肉作為替代終止點的試驗被用來回顧現有的證據。 本研究的主要目的在於系統性的評量補充飲食中的鈣質對於大腸癌的發生,以及大腸息肉症的發生與再發生的影響。 我們檢索了 Cochrane Controlled Trials Register, the Cochrane Colorectal Cancer Group specialised register、MEDLINE、Cancerlit 和Embase等資料庫,檢索工作一直持續到2007年7月,被確認的試驗中的參考文獻清單也被審閱以取得更多的試驗資料,並且針對回顧性質的文獻進行詳細的閱覽。 針對補充飲食中鈣質是否會影響人類大腸癌和大腸息肉症發展進行的隨機性對照試驗會被納入本研究中,針對成年人、因為家族病史而具有罹患大腸癌高風險的成人、以前曾經罹患過大腸息肉症或是炎症性腸病(inflammatory bowel disease)的患者都會被納入研究中,由家族性大腸息肉症患者所取得的數據則會被排除於研究之外,主要的試驗成果包括大腸癌的發生、任何新的大腸息肉的發生和再發生,次要的試驗成果包括了任何需要中斷鈣質補充的不良事件,和在研究結束之前被移出試驗。 有2個審閱者會分別進行數據的選取、評估試驗品質和解決認知差異,試驗成果係以OR值搭配95%信心區間進行表示,數據會經由固定效應模式來加以合併。 有2個包括1346位受試者的試驗符合本研究的納入標準,這2個試驗都具有良好的實驗設計、為雙盲性試驗、設有安慰對照組,並納入先前患有息肉的患者,受試者依分組每天補充劑量為1200毫克的元素型態鈣質,平均補充時間為4年,或是每天補充2000微克的劑量3年,兩個組別之間失去後續追蹤的比例分別為14%和11%,當將兩個試驗結果結合視之時,可以發現降低了大腸息肉的復發(OR值為0.74,95%的信心區間介於0.59至0.95之間)。 雖然由2個RCT試驗所得到的證據可以推測補充鈣質可能可以中等程度的預防大腸息肉症,但是並沒有足夠的證據可以建議正常的進行鈣質補充可以預防大腸癌。 Supplémentation en calcium pour la prévention du cancer colorectal et des polypes adénomateux On considère que plusieurs facteurs alimentaires sont impliqués dans l'incidence croissante du cancer colorectal dans les pays industrialisés. Les données expérimentales et épidémiologiques suggèrent (sans toutefois apporter de preuves concluantes) qu'un apport élevé en calcium pourrait jouer un rôle protecteur. Les études d'intervention portant sur le cancer colorectal en tant que critère de jugement sont difficiles à réaliser en raison du grand nombre de patients et des longues...


    • 1 March 2007
      • Vol. 9  (3) , 180-2

    Prevention in Halakhah.

    by Michael A Weingarten

    Preventive medicine is taking an increasingly central place in modern clinical practice, at least in primary care. What, if anything, does the Jewish rabbinic tradition have to say about keeping healthy? The delayed response of contemporary rabbis to the dangers of smoking, in particular, raises questions about the underlying principles that Halakhah employs to approach health promotion. As is often the case in Halakhah, we may detect different streams of thought in the classical sources, which may be felt in the way contemporary issues are handled. Three approaches will be discussed. First, Maimonides, famous for the practical preventive approach in his medical writings, makes his philosophy clear both in his halakhic works and in his Guide for the Perplexed. For him, a healthy body is a prerequisite for a healthy soul. We must be free of physical suffering in order to be able to do the work of perfecting our souls. Second, the view that health is the reward for goodness and illness a punishment for sin as expounded or implied in the writings of Nahmanides, and of Ibn Ezra: the way to good health is to lead a good life. Third, an early midrashic source picked up again much later by Rabbi Israel Meir Kagan (the Hafetz Hayim) gives the argument from custodianship--since the body is divine property we have a duty to look after it well. So for Maimonides there is a prior duty to keep healthy, while for Nahmanides the prior requirement is to repent of sin. For the Hafetz Hayim, keeping the body healthy is an independent duty in its own right. These then are the differences in basic approach that may affect the emphases that different rabbis today place on health maintenance and promotion.

  • Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps

    by Ma Weingarten, A Zalmanovici, J Yaphe

    Several dietary factors have been considered to be involved in the increasing incidence of colorectal cancer in industrialised countries. Experimental and epidemiological evidence has been suggestive but not conclusive for a protective role for high dietary calcium intake. Intervention studies with colorectal cancer as an endpoint are difficult to perform owing to the large number of patients and the long follow-up required; studies using the appearance of colorectal adenomatous polyps as a surrogate endpoint are therefore considered in reviewing the existing evidence. This systematic review aims to assess the effect of supplementary dietary calcium on the incidence of colorectal cancer and the incidence or recurrence of adenomatous polyps. We searched the Cochrane Controlled Trials Register, the Cochrane Colorectal Cancer Group specialised register, MEDLINE, Cancerlit, and Embase, to April 2002. The reference lists of identified studies were inspected for further studies, and the review literature was scrutinized. Randomised controlled trials of the effects of dietary calcium on the development of colonic cancer and adenomatous polyps in humans are reviewed. Studies of healthy adults and studies of adults at higher risk of colon cancer due to family history, previous adenomatous polyps, or inflammatory bowel disease were considered; data from subjects with familial polyposis coli are excluded. The primary outcomes were the occurrence of colon cancer, and occurrence or recurrence of any new adenomas of the colon. Secondary outcomes were any adverse event that required discontinuation of calcium supplementation, and drop-outs before the end of the study. Two reviewers independently extracted data, assessed trial quality and resolved discrepancies by consensus. The outcomes were reported as odds ratios (OR) with 95% confidence intervals (CI). The data were combined with the fixed effects model. Two studies with 1346 subjects met the inclusion criteria. Both trials were well designed, double - blind, placebo controlled trials, included participants with previous adenomas. The doses of supplementary elemental calcium used were 1200 mg daily for a mean duration of 4 years, and 2000 mg/day for three years. The rates of loss to follow -up were 14 % and 11%. For the development of recurrent colorectal adenoma, a reduction was found (OR 0.74, CI 0.58,0.95) when the results from both trials were combined. Although the evidence from two RCTs suggests that calcium supplementation might contribute to a moderate degree to the prevention of colorectal adenomatous polyps, this does not constitute sufficient evidence to recommend the general use of calcium supplements to prevent colorectal cancer.


  • Assessing ethics of trials in systematic reviews

    by Michael A Weingarten, Mical Paul, Leonard Leibovici

    Why include ethical information? The main reason for including ethics in the checklist of systematic reviews is to increase awareness in the scientific community about the need for high ethical standards in research on humans. The proposal would also encourage reviewers to identify those occasional studies that were so unethical that there may be doubts about the morality of using the results. Although such trials are rare, history has given us too many real examples to allow us to be complacent.2 3 Opinions differ on whether it is justified to disseminate the results of such studies.4 Either way, a conscious decision should be made and revealed to readers of the review. Issues around ethical quality overlap importantly with the central issues of the validity, reliability, and generalisability of research findings. They relate to some of the more subtle potential sources of bias in experimental clinical research. It is thus important to include ethical assessment in systematic reviews on prudential grounds as well as on moral grounds. The results of ethically sound trials may be more reliable than those from other trials. In a review of 767 randomised controlled trials published during 1993-5 in the New England Journal of Medicine, Lancet, BMJ, and JAMA, trials of higher methodological quality were more likely to provide information about their ethical aspects; so it seems that more reliable research is also more sensitive to the ethical requirements of research.5


    • 1 December 2003
      • Vol. 53  (497) , 960-2

    With luck, good doctors make a difference.

    by Michael A Weingarten

    The luckiest general practitioners work in an ideal environment with a perfect patient population, their clinical intuitions are always correct, they face difficulties with total equanimity, and they get on with all their patients. In the real world one needs a lot of luck for things to go right. This paper applies the philosophical concept of 'moral luck' to the world of general practice.

  • A comparison of videotape and audiotape assessment of patient-centredness in family physicians’ consultations

    by Michael A. Weingarten, John Yaphe, Dalia Blumenthal, Menahem Oren, Alon Margalit


    • 1 March 2000
      • Vol. 2  (3) , 207-10

    Diabetes and ischemic heart disease among Yemenite immigrants in Israel.

    by M A Weingarten, I Katzir, E Sprecher, S Kobzantsev, C Zelzer, E Kahan

    The pattern of diabetes and ischemic heart disease among emigrants from pre-industrialized societies to more developed countries may be explained by both genetic and environmental factors. To describe and interpret the pattern of diabetes and ischemic heart disease among Yemenite immigrants in Israel and their second-generation offspring. Medical record charts of adult Yemenites were surveyed in a primary care health center, and the data were compared with prevalence rates derived from a non-Yemenite population. There was a marked excess of non-insulin dependent diabetes mellitus among Yemenite immigrants over 45 years of age, but not of hypertension or ischemic heart disease. Yemenites with diabetes were far less likely to develop ischemic heart disease than non-Yemenites with diabetes (odds ratio for non-Yemenites compared with Yemenites, 3.5; confidence interval 1.54 < OR < 7.77). There was less of an association between diabetes and ischemic heart disease among Yemenites. This finding requires further investigation of the relative roles of genetic and environmental factors.